EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies

Saeid Iranzadeh iD, Davood Dalil, Soroush Kohansal, Mahdi Isakhani

Journal of Pharmacy and Pharmacology · 01.08.2024 · 76 (8) · 967-982

DOI: 10.1093/jpp/rgae041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.08.2024. Verfasst von Saeid Iranzadeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran. Hauptthemen laut MEDLINE: Naphthoquinones, Breast Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Breast cancer is a prevalent disease that has a substantial impact on women’s mortality rates. Shikonin, a naphthoquinone derived from Lithospermum erythrorhizon, has demonstrated substantial anticancer effects. This study aims to conduct a comprehensive review of the latest research findings regarding the therapeutic efficacy of shikonin in the context of breast cancer treatment, with a specific emphasis on elucidating the underlying molecular mechanisms.

Methods

A comprehensive literature review was conducted on shikonin and breast cancer by searching PubMed, Scopus, Web of Science, and Google Scholar databases. Key findings Shikonin significantly reduces tumor cell viability, proliferation, migration, invasion, and metastasis in both in vivo and in vitro across all breast cancer subtypes. Additionally, when combined with other pharmaceutical agents, it exhibits synergistic effects. Shikonin stimulates immunogenic cell death, resulting in apoptosis and necroptosis. The induction of immunogenic cell death by shikonin enhances the immunogenicity of breast cancer cells, leading to its involvement in the development of dendritic cell-based tumor vaccines against breast cancer.

Conclusion

Shikonin exhibits potent anti-breast cancer properties and shows significant potential for the advancement of immunotherapeutic approaches against breast cancer, as well as enhancing the efficacy of conventional treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesBreast NeoplasmsHumansFemaleAnimalsApoptosisCell ProliferationLithospermumAntineoplastic Agents, PhytogenicCell Survival

Stichwörter der Autor:innen

breast cancerchemotherapyimmunotherapynaphthoquinonephytochemicalshikonin

Substanzen

NaphthoquinonesshikoninAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Student Research Committee, Faculty of Medicine, Shahed University, Tehran, Iran.

ORCID-Profile: Saeid Iranzadeh

Zitieren

APA

Iranzadeh, S., Dalil, D., Kohansal, S., & Isakhani, M. (2024). Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies. Journal of Pharmacy and Pharmacology, 76(8), 967-982. https://doi.org/10.1093/jpp/rgae041

Vancouver

Iranzadeh S, Dalil D, Kohansal S, Isakhani M. Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies. Journal of Pharmacy and Pharmacology. 2024;76(8):967-982. doi:10.1093/jpp/rgae041

BibTeX
@article{Iranzadeh2024,
  author = {Iranzadeh, Saeid and Dalil, Davood and Kohansal, Soroush and Isakhani, Mahdi},
  title = {Shikonin in breast cancer treatment: a comprehensive review of molecular pathways and innovative strategies},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {76},
  number = {8},
  pages = {967--982},
  doi = {10.1093/jpp/rgae041}
}
Kostenlos starten →